论文部分内容阅读
目的探讨阿奇霉素与红霉素治疗小儿支原体肺炎的临床效果差异。方法回顾性分析2009年1月~2013年1月本院收治的145例小儿支气管肺炎患儿的临床资料。结果阿奇霉素组患儿的退烧时间、咳嗽消失时间、肺啰音消失时间明显少于红霉素组,经比较,P<0.05,差异具有统计学意义。红霉素组患儿总有效率为67.57%,阿奇霉素组患儿总有效率为91.55%,明显高于红霉素组,经比较,P<0.05,差异具有统计学意义。结论阿奇霉素治疗小儿支原体肺炎相较红霉素,疗效更为确切,症状改善更为迅速,值得临床推广应用。
Objective To investigate the clinical effects of azithromycin and erythromycin in children with mycoplasma pneumonia. Methods The clinical data of 145 children with bronchopneumonia treated in our hospital from January 2009 to January 2013 were retrospectively analyzed. Results In the azithromycin group, the time of fever, the disappearance of cough and the disappearance of pulmonary rales were significantly less than those of the erythromycin group. The differences were statistically significant (P <0.05). The total effective rate was 67.57% in erythromycin group and 91.55% in azithromycin group, which was significantly higher than that of erythromycin group (P <0.05). The difference was statistically significant. Conclusion Azithromycin treatment of children with mycoplasma pneumonia compared with erythromycin, the curative effect is more exact, the symptoms improved more rapidly, it is worthy of clinical promotion and application.